ATE206423T1 - Heterocyclische verbindungen zur behandlung von myokard-ischemia - Google Patents

Heterocyclische verbindungen zur behandlung von myokard-ischemia

Info

Publication number
ATE206423T1
ATE206423T1 AT96927083T AT96927083T ATE206423T1 AT E206423 T1 ATE206423 T1 AT E206423T1 AT 96927083 T AT96927083 T AT 96927083T AT 96927083 T AT96927083 T AT 96927083T AT E206423 T1 ATE206423 T1 AT E206423T1
Authority
AT
Austria
Prior art keywords
pct
optionally branched
compounds
heterocyclic compounds
myocardial ischemia
Prior art date
Application number
AT96927083T
Other languages
English (en)
Inventor
Jean-Pierre Rieu
Jean-Francois Patoiseau
Gareth W John
Bruno Legrand
Jean-Pierre Valentin
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Application granted granted Critical
Publication of ATE206423T1 publication Critical patent/ATE206423T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT96927083T 1995-07-26 1996-07-25 Heterocyclische verbindungen zur behandlung von myokard-ischemia ATE206423T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9509079A FR2737207B1 (fr) 1995-07-26 1995-07-26 Nouvelles n-heterocyclyl-1-aryloxyalcoyl-4-piperidinamines substituees, leur preparation et leur application en therapeutique
PCT/FR1996/001176 WO1997005134A1 (fr) 1995-07-26 1996-07-25 Composes heterocycliques pour le traitement de l'ischemie myocardique

Publications (1)

Publication Number Publication Date
ATE206423T1 true ATE206423T1 (de) 2001-10-15

Family

ID=9481394

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96927083T ATE206423T1 (de) 1995-07-26 1996-07-25 Heterocyclische verbindungen zur behandlung von myokard-ischemia

Country Status (17)

Country Link
US (1) US6011032A (de)
EP (1) EP0842174B1 (de)
JP (1) JPH11509857A (de)
KR (1) KR19990035986A (de)
CN (1) CN1103338C (de)
AT (1) ATE206423T1 (de)
AU (1) AU707950B2 (de)
BR (1) BR9609911A (de)
CA (1) CA2228691A1 (de)
DE (1) DE69615696T2 (de)
DK (1) DK0842174T3 (de)
ES (1) ES2165514T3 (de)
FR (1) FR2737207B1 (de)
MX (1) MX9800705A (de)
NZ (1) NZ315347A (de)
PT (1) PT842174E (de)
WO (1) WO1997005134A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2788771B1 (fr) * 1999-01-22 2001-04-13 Pf Medicament Nouvelles 1,2-alcoyl-1-[1-[aryl (alcoyl) oxyalcoyl] piperidin-4-yl]-3-aryl isothiourees substituees, leur preparation et leur application en therapeutique
FR2788775B1 (fr) * 1999-01-22 2001-04-13 Pf Medicament Nouvelles n-alcoyl-n-[1-(omega-(arylalcoyloxy)alcoyl] piperidin-4-yl]-4h-3,1-benzo(thia/oxa)zines-2-amines substituees, leur preparation et leur application en therapeutique
WO2000066579A1 (en) * 1999-04-28 2000-11-09 Banyu Pharmaceutical Co., Ltd. Processes for the preparation of piperidylmethylpyridine derivatives
FR3001151B1 (fr) 2013-01-21 2016-04-08 Pf Medicament Association d'un bloqueur de courant sodique lent et d'un inhibiteur du courant if sinusal et les compositions pharmarceutiques la contenant
CN114349745B (zh) * 2022-01-14 2023-12-08 黑龙江中医药大学 一种用于治疗心肌缺血的药物及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1260474A (en) * 1984-12-03 1989-09-26 Raymond A. Stokbroekx Benzoxazol- and benzothiazolamine derivatives

Also Published As

Publication number Publication date
FR2737207A1 (fr) 1997-01-31
AU6703196A (en) 1997-02-26
BR9609911A (pt) 1999-03-02
EP0842174A1 (de) 1998-05-20
DK0842174T3 (da) 2002-01-28
ES2165514T3 (es) 2002-03-16
JPH11509857A (ja) 1999-08-31
NZ315347A (en) 2000-01-28
KR19990035986A (ko) 1999-05-25
WO1997005134A1 (fr) 1997-02-13
MX9800705A (es) 1998-10-31
PT842174E (pt) 2002-03-28
CN1103338C (zh) 2003-03-19
FR2737207B1 (fr) 1997-10-17
CA2228691A1 (fr) 1997-02-13
AU707950B2 (en) 1999-07-22
EP0842174B1 (de) 2001-10-04
US6011032A (en) 2000-01-04
DE69615696D1 (de) 2001-11-08
CN1193972A (zh) 1998-09-23
DE69615696T2 (de) 2002-07-11

Similar Documents

Publication Publication Date Title
ATE215078T1 (de) Verbessertes verfahren zum herstellen von geschützten 3,4-dihydroxybuttersäure estern
NO952129L (no) Oksalylamino-benzofuran- og benzotienyl-derivater
ATE278322T1 (de) Mittel zur bekämpfung von pflanzenschädlingen
ES2054826T3 (es) Peptidos con actividad inhibidora de colagenasa.
SE8404462L (sv) Mellanprodukt
NO975663L (no) Semikarbazoner med CNS aktivitet og farmasöytiske preparater inneholdende de samme
DE69607650D1 (de) 2,3,5-trimethyl-hydroxyanilid-derivative, ihre herstellung und ihre theraoeutische verwendung
ES2177058T3 (es) Compuestos eter piperidinilaminometil trifluorometil ciclicos como antagonistas de la sustancia p.
PT1044186E (pt) Composto 2-benzilamino-2-fenil-acetamida substituidos
ATE218538T1 (de) Azahexan-derivate als substratisostere von retroviralen aspartat-proteasen
DE69615696D1 (de) Heterocyclische verbindungen zur behandlung von myokard-ischemia
EP0921122A4 (de) Neue epoxysuccinamid-derivate oder ihre salze
ATE233741T1 (de) Antivirale 2,4-pyrimidindion-derivate und verfahren zu ihrer herstellung
NO970340D0 (no) Organiske forbindelser
PT100682A (pt) Agentes anti-helminticos derivados de benzimidazole e processo para a sua preparacao
ID21677A (id) Proses pembuatan n-[2-(dimetilamino)etil]-akridin-4-karboksamida
DK0675890T3 (da) Kondenserede benzo(d)isoxazolderivater og anvendelse deraf som psykoaktive midler
CO4410332A1 (es) Oxazoles y tiazoles sustituidos
ATE64095T1 (de) Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis.
ES2164665T3 (es) Inhibidores de proteasas retrovirales.
DE3671014D1 (de) Cyclohexan-1,3-dionderivate, diese enthaltende zusammensetzungen, verfahren zu deren herstellung und deren verwendung als herbizide und pflanzenwachstumsregulatoren.
YU49004B (sh) LANOSTA-7,9-DIEN-3Гџ, 32-DIOL I POSTUPAK ZA NJEGOVO DOBIJANJE

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee